Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Express Scripts Rises After Increase in Prescriptions

Express Scripts Holding Co., the U.S.’s largest pharmacy benefit manager after buying Medco Health Solutions Inc., rose the most in five weeks after the company reported prescription volume increased more than analysts expected.

Express Scripts gained 1.4 percent to $55.10 at 4 p.m. in New York trading today. The stock has declined 6.8 percent in the past 12 months.

The volume of adjusted prescription claims Express Scripts handled during the first quarter increased 3.6 percent to about 193 million from a year earlier, the St. Louis-based company said yesterday. Revenue increased 9.4 percent to $12.1 billion, beating analysts’ estimates of $11.5 billion.

“They reassured everybody that everything’s on track” with the merger, analyst Dave Shove of BMO Capital Markets in New York said in a phone interview. “And the quarter on scrip metrics was good. The stock’s lifting on all of that.”

The company shipped 14 million prescriptions to customers by mail, a 6 percent increase from a year earlier that was helped by Walgreen Co.’s decision to withdraw its drug stores from Express Scripts’ network, Chief Executive Officer George Paz said on a conference call with analysts today.

Profit excluding one-time items was 73 cents per share, missing analysts’ average estimate of 77 cents.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.